Using ex-vivo co-culture systems of breast cancer cells and mouse bones, others have also shown that a CXCL5/CXCR2 (the IL-8 receptor-β) signaling axis might be involved in regulating the balance between cancer cell quiescence/dormancy and subsequent breast cancer outgrowth in bone [102]. This evidence concerns the gene CXCL5 and breast carcinoma.